Driving Artificial Pancreas Device System Market Growth in 2025: The Role of Impact Of Increasing Pancreatic Cancer Prevalence On The Artificial Pancreas Device System Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Pancreas Device System Market Size Growth Forecast: What to Expect by 2025?
The market for artificial pancreas device systems has seen rapid expansion in recent years. The market size is expected to increase from $1.81 billion in 2024 to $2.07 billion in 2025, experiencing a compound annual growth rate (CAGR) of 14.1%. Factors contributing to the growth during the historical period include a surge in investment, increased government involvement in clinical research, a growing demand for automated glycemic control systems, significant industry-led R&D initiatives, and a rising elderly population.

How Will the Artificial Pancreas Device System Market Size Evolve and Grow by 2029?
Predictions indicate a swift expansion in the artificial pancreas device system market over the upcoming years. The market is anticipated to reach $3.48 billion by 2029, with a compound annual growth rate (CAGR) of 13.9%. This expected surge during the forecast period could be due to the increasing cases of diabetes and pancreatic cancer, growing incidences of diabetes and obesity, rising demand for minimally invasive (MI) drug delivery systems, and progressive advancements in diabetes management technology. Significant trends projected during this period encompass tech-based innovations, increased research and development efforts, rising product approvals, burgeoning partnerships, collaborations, and the burgeoning trend of tele-consultancy for outcomes monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Drivers Are Propelling the Growth of Artificial Pancreas Device System Market Forward?
The anticipated rise in pancreatic cancer cases is set to fuel the expansion of the artificial pancreas device system market in the future. Pancreatic cancer, a deadly type of tumor that begins in the pancreas-a gland situated behind the stomach-is often triggered by a mix of lifestyle, genetics, medical, and environmental factors. It also includes genetic mutations leading to hereditary pancreatitis, resulting in chronic pancreas inflammation. An artificial pancreas device system (APDS) is designed mainly to assist those with diabetes in managing their blood glucose levels through automatic monitoring and appropriate insulin dispensing. For example, in March 2024, Cancer Australia, a government entity, calculated that 4,506 fresh cases of pancreatic cancer were detected in 2023, marking a rise from the 3,751 cases recorded over the previous five years. Therefore, the growing incidence of pancreatic cancer is accelerating the expansion of the artificial pancreas device system market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Emerging Trends Are Transforming the Artificial Pancreas Device System Market in 2025?
Leading corporations in the artificial pancreas device system market are coming up with automated insulin delivery mechanisms aimed at improving diabetes management. These systems autonomously monitor blood glucose levels and provide suitable insulin doses. The objective is to mimic a healthy pancreas' operation, thereby minimizing the constant monitoring of blood sugar and manual insulin dosage for diabetes patients. For instance, Beta Bionics, a medical equipment producer based in the US, secured FDA 510(k) approval in May 2023 for its iLet Insulin-Only Bionic Pancreas System. This is an automated insulin delivery device and artificial pancreas system that autonomously calculates and administers insulin amounts to regulate blood sugar levels. It utilizes a closed-loop system to tweak insulin delivery based on the user's glucose levels as tracked by a continuous glucose monitor (CGM) attached. Only the user's body weight and an estimation of meal size are necessary for automatic insulin delivery adjustment.

What Are the Key Segments in the Artificial Pancreas Device System Market?
The artificial pancreas device system market covered in this report is segmented -

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Who Are the Key Players Shaping the Artificial Pancreas Device System Market's Competitive Landscape?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

What Geographic Markets Are Powering Growth in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.